Organisation paid for research Program year 2021 Source: CMS Open Payments

Advanced Med Research Inc

Neither a doctor nor a teaching hospital

Research payments

$321,806

60 payments

Through program year 2021, Advanced Med Research Inc is reported as receiving $321,806 in research payments, across 60 payments.

By program year

3 rows

Year	Kind	Amount	Payments
2021	Research	$89,043	22
2020	Research	$62,867	21
2019	Research	$169,896	17

Breakdown

Who paid Research payments · program years 2019–2021

AbbVie, Inc. $321,806 60 payments

Studies the money was for Research payments · program years 2019–2021

M16-048 $125,535 2 payments
M15-997 $80,876 28 payments
A Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ABBV-157 in Healthy Volunteers and in Subjects with Chronic Plaque Psoriasis $48,829 2 payments
M16-833 $19,904 5 payments
A Phase 2, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Risankizumab in Adult Subjects with Moderate to Severe Hidradenitis Suppurativa $19,024 7 payments
A multicenter, open Label study to assess the safety and efficacy of risankizumab for maintenance in moderate to severe plaque type psoriasis (LIMMITLESS) $16,930 9 payments
M19-164 $6,447 3 payments
A Phase 3b, Multicenter, Interventional, Open-label Study of Adult Subjects with Moderate to Severe Plaque Psoriasis who have a Suboptimal Response to Secukinumab or Ixekizumab and are Switched to Risankizumab $4,260 4 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.